Pro Medicus Limited, commonly referred to as Pro Medicus, is a leading provider of radiology information systems and imaging software solutions, headquartered in Australia. Established in 1983, the company has made significant strides in the healthcare technology sector, particularly in the fields of medical imaging and radiology. With a strong presence in Australia, North America, and Europe, Pro Medicus has positioned itself as a key player in the industry. The company’s core offerings include advanced imaging solutions that enhance workflow efficiency and improve patient care. Pro Medicus is renowned for its unique cloud-based platform, which allows for seamless integration and accessibility across various healthcare settings. Notable achievements include partnerships with major healthcare institutions and a consistent track record of innovation, solidifying its market position as a trusted provider in the healthcare technology landscape.
How does Pro Medicus's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Computer Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Pro Medicus's score of 23 is lower than 66% of the industry. This can give you a sense of how well the company is doing compared to its peers.
In 2024, Pro Medicus reported total carbon emissions of approximately 120,900 kg CO2e, comprising 1,900 kg CO2e from Scope 1 and about 118,900 kg CO2e from Scope 2 emissions. This marks a decrease from 2023, when emissions were about 98,600 kg CO2e, with Scope 1 emissions remaining constant at 1,900 kg CO2e and Scope 2 emissions at approximately 96,700 kg CO2e. In 2022, the total emissions were around 116,500 kg CO2e, with similar Scope 1 and Scope 2 figures. The highest recorded emissions were in 2021, at about 127,000 kg CO2e. Pro Medicus has not set specific reduction targets or initiatives under the Science Based Targets initiative (SBTi) or other climate pledges. The company does not disclose any Scope 3 emissions data, indicating a potential area for future focus. All emissions data is sourced directly from Pro Medicus Limited, with no cascaded data from parent or related organizations. Overall, Pro Medicus is actively monitoring its carbon footprint, with a clear trend of emissions reduction over the past few years, particularly in Scope 2 emissions.
Access structured emissions data, company-specific emission factors, and source documents
2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|
Scope 1 | 1,900 | 0,000 | 0,000 | 0,000 |
Scope 2 | 125,100 | 000,000 | 00,000 | 000,000 |
Scope 3 | - | - | - | - |
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Pro Medicus is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.